Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RENT.COM.AU LIMITED Capital/Financing Update 2003

Jun 26, 2003

65722_rns_2003-06-26_dab7613e-a957-47cf-a60f-2259bda9eb04.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Appendix 3B

New issue announcement, application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 1/7/96. Origin: Appendix 5. Amended 1/7/98, 1/9/99, 1/7/2000, 30/9/2001, 11/3/2002, 1/1/2003.

Name of entity

Select Vaccines Limited

ABN

25 062 063 692

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

$\mathbf{1}$ $\pm$ Class of $\pm$ securities issued or to be Ordinary Shares $1.$ issued 2. Options 3. Options 4. Ordinary Shares 5. Options Number of +securities issued or to $\overline{2}$ 1. 12,220,000 be issued (if known) or maximum 2. 6,110,000 number which may be issued 3, 6,750,000 4. 3,000,000 5. 2,000,000

3 Principal terms of the +securities (eg, if options, exercise price and expiry date; if partly paid *securities, the amount outstanding and due dates $for$ payment; if *convertible securities, the conversion price and dates for conversion)

Do the *securities rank equally in all $\mathbf{A}$ respects from the date of allotment with an existing *class of quoted *securities?

If the additional securities do not rank equally, please state:

  • the date from which they do
  • the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment
  • the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

$\overline{5}$ Issue price or consideration

Purpose of the issue $\epsilon$ (If issued as consideration for the acquisition of assets, clearly identify those assets)

  • $\mathbf{I}$ . Pari passu with existing ordinary Shares

  • $2.$ Exercisable at 20 cents on or before 31st May 2008

    1. Options exercisable at 20 cents on or before 31st May 2008, escrowed until 3 July 2005
    1. Ordinary Shares, escrowed until 3 July 2005
    1. Options exercisable at 20 cents on or before 30th June 2006, escrowed to 27 June 2004
  • Ť. Yes

    1. Yes, upon exercise
    1. Yes, upon release from escrow and exercise
    1. Yes, upon release from escrow
    1. Yes, upon release from escrow and exercise
  • $\overline{1.20 \text{ cents}}$

    1. Free 1-for-2 attaching
    1. In accordance with resolutions passed at the Company's AGM, 19th June 2003
  • In accordance with resolutions passed $4.$ at the Company's AGM, 19th June 2003

  • $5.$ In accordance with resolutions passed at the Company's AGM, 19th June 2003

Change of business and capital raising in accordance with Resolutions approved at the Company's AGM on $19^{th}$ June 2003, the Prospectus and Supplementary Prospectus dated $3rd$ and $18th$ June respectively.

+ See chapter 19 for defined terms.

7 Dates of entering *securities intouncertificatedholdingsOFdespatch of certificates $27th$ June 2003
Number + Class
8 Number and + class of all + securities 21,426,804 Ordinary Shares
quoted on ASX (including the 7,637,987 Options (SLTO)
securities in clause 2 if applicable) 6,110,000 Options (SLTOA)
Number + Class
9 Number and + class of all + securitiesnot quoted on ASX (including thesecurities in clause 2 if applicable) 3,000,000 Ordinarysharesescrowed until 3 July2005
6,750,000 Options exercisable at$$0.20$ on or before 31May 2008 escroweduntil 3 July 2005
2,000,000 Options exercisable at$0.20 on or before 30June 2006 escrowed to27 June 2004
10 Dividend policy (in the case of atrust, distribution policy) on the Unchanged

increased capital (interests)

$\mathbf{1}$ securityholderapprovalÍsrequired?
$12 ,$ Is the issue renounceable or non-renounceable?
13 Ratio in which the "securities will beoffered
14 + Class of + securities to which theoffer relates
15 *Recorddatedeterminetoentitlements
16 Will holdings on different registers(or subregisters) be aggregated forcalculating entitlements?
17 Policy for deciding entitlements inrelation to fractions
18 Names of countries in which theentity has *security holders who willnot be sent new issue documents
Note: Security holders must be told how theirentirlements are to be dealt with.Cross reference: rule 7.7.
19 Closingdateforofreceiptacceptances or renunciations
20 Names of any underwriters
21 Amount of any underwriting fee orcommission
22 Names of any brokers to the issue
23 Fee or commission payable to thebroker to the issue

Part 2 - Bonus issue or pro rata issue

+ See chapter 19 for defined terms.

  • 24 Amount of any handling fee payable to brokers who lodge acceptances or renunciations on behalf of *security holders
  • 25 If the issue is contingent on "security holders' approval, the date of the meeting
  • 26 Date entitlement and acceptance form and prospectus or Product Disclosure Statement will be sent to persons entitled
  • $27$ If the entity has issued options, and the terms entitle option holders to participate on exercise, the date on which notices will be sent to option holders
  • Date rights trading will begin (if 28 applicable)
  • $\overline{29}$ Date rights trading will end (if applicable)
  • 30 How do *security holders sell their entitlements in full through a broker?
  • $31$ How do *security holders sell part of their entitlements through a broker and accept for the balance?
  • 32 How do +security holders dispose of their entitlements (except by sale through a broker)?
  • 33 *Despatch date

Part 3 - Ouotation of securities

You need only complete this section if you are applying for quotation of securities

Additional securities forming a new class of securities

Tick to indicate you are providing the information or documents

35 If the "securities are "equity securities, the names of the 20 largest holders of the additional "securities, and the number and percentage of additional "securities held by those holders

If the "securities are "equity securities, a distribution schedule of the additional 36 *securities setting out the number of holders in the categories $1 - 1.000$ $1,001 - 5,000$ $5,001 - 10,000$ $10.001 - 100.000$ 100,001 and over

37

A copy of any trust deed for the additional "securities

Entities that have ticked box 34(b)

38 Number of securities for which 4quotation is sought

39 Class of +securities for which quotation is sought

+ See chapter 19 for defined terms.

$\overline{40}$ Do the +securities rank equally in all respects from the date of allotment with an existing +class of quoted *securities?

If the additional securities do not rank equally, please state:

  • the date from which they do $\ddot{\phantom{a}}$
  • the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment
  • the extent to which they do not rank equally, other than in relation to the next dividend, distribution $\sigma$ interest payment
  • 41 Reason for request for quotation now

Example: In the case of restricted securities, end of restriction period

(if issued upon conversion of another security, clearly identify that other security)

42 Number and +class of all +securities quoted on ASX (including the securities in clause 38)

Number + Class

Ouotation agreement

  • $\ddot{\phantom{a}}$ *Ouotation of our additional *securities is in ASX's absolute discretion. ASX may quote the "securities on any conditions it decides.
  • $\overline{2}$ We warrant the following to ASX.
    • The issue of the *securities to be quoted complies with the law and is not for an illegal purpose.
    • There is no reason why those *securities should not be granted *quotation. L
    • An offer of the "securities for sale within 12 months after their issue will not require disclosure under section $707(3)$ or section $1012C(6)$ of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

  • Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any +securities to be quoted and that no-one has any right to return any *securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the *securities be quoted.
  • We warrant that if confirmation is required under section 1017F of the Corporations Act in relation to the *securities to be quoted, it has been provided at the time that we request that the "securities be quoted.
  • If we are a trust, we warrant that no person has the right to return the *securities to be quoted under section 1019B of the Corporations Act at the time that we request that the "securities be quoted.
  • $\mathfrak{Z}$ We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.
  • $\overline{4}$ We give ASX the information and documents required by this form. If any information or document not available now, will give it to ASX before *quotation of the "securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

Sign here:

(Director/Company secretary)

Date: .27/06/03

Print name: Philip Hains

+ See chapter 19 for defined terms.

$\overline{\hspace{1cm}}\overline{\hspace{1cm}}\overline{\hspace{1cm}}\overline{\hspace{1cm}}\overline{\hspace{1cm}}\overline{\hspace{1cm}}\overline{\hspace{1cm}}\overline{\hspace{1cm}}\hspace{1cm}}$

+ See chapter 19 for defined terms.